Equities

MicroPort NeuroScientic Corp

MicroPort NeuroScientic Corp

Actions
Health CareMedical Equipment and Services
  • Price (HKD)9.16
  • Today's Change-0.19 / -2.03%
  • Shares traded1.34m
  • 1 Year change-34.76%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MicroPort NeuroScientic Corp is an investment holding company mainly engaged in research, development, and production of neuro-interventional medical devices. The Company's product portfolio covers three major areas of cerebrovascular diseases, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The Company provides integrated solutions for patients and doctors with cerebrovascular diseases, including promotion and education regarding the surgical methods and products, recommendations for treatment options, training on surgery and surgical devices, clinical support and postoperative follow-ups. The Company's main products include Tubridge Flow-diverting Stent, Fastrack Microcatheter System, WILLIS Intracranial Stent Graft, and others.

  • Revenue in HKD (TTM)832.13m
  • Net income in HKD241.71m
  • Incorporated2020
  • Employees534.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IVD Medical Holding Ltd3.29bn279.77m2.89bn815.008.600.66148.990.87890.20690.20692.442.690.62022.186.954,099,518.005.285.187.446.6722.6720.758.517.531.287.490.1926--12.3549.4913.4118.1519.77--
Modern Dental Group Ltd3.27bn408.15m3.36bn7.18k8.271.246.141.030.4290.4293.442.850.84719.385.14465,149.5010.527.0512.358.3453.4050.7712.419.242.5810.750.240539.9812.086.5083.3036.462.42--
OrbusNeich Medical Group Holdings Ltd1.18bn301.36m3.45bn1.28k11.501.1910.182.930.36270.36271.423.500.38391.154.20943,274.209.83--10.63--68.71--25.61--8.32--0.0214--12.45--143.76------
China Isotope & Radiation Corp7.20bn428.14m3.51bn3.13k8.200.68913.160.48771.341.3422.5215.930.5253.371.802,319,527.006.266.5712.8513.2651.6359.8911.9212.621.6757.070.218728.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd712.85m27.55m3.60bn756.00130.751.0755.625.060.08410.08412.1810.290.19571.16473.84931,828.600.7561--0.8234--71.62--3.86--3.38--0.0255--57.97--30.66------
Shanghai INT Medical Instruments Co Ltd865.15m189.59m4.95bn1.73k24.972.7419.135.721.131.135.1110.250.41282.0812.01552,105.408.818.6310.419.7660.1659.4421.3426.162.06--0.038431.8028.5029.9618.7921.7645.75--
MicroPort NeuroScientic Corp832.13m241.71m5.41bn534.0022.502.9718.496.500.41550.41551.433.150.38991.178.301,457,322.0010.91--12.61--74.12--27.97--4.53--0.0282--21.61--768.73------
AK Medical Holdings Ltd1.18bn202.79m5.64bn974.0027.682.1118.944.760.18140.18141.062.380.35140.75731.971,125,532.006.029.277.4611.2860.9165.0617.1321.782.58--0.04822.653.9712.74-11.074.6721.675.88
Yidu Tech Inc866.96m-209.41m5.76bn902.00--1.34--6.64-0.1991-0.19910.82444.070.1658114.901.36961,148.50-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96---2.99--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd439.41m231.67m5.99bn239.0025.862.9724.5913.640.66810.66811.275.830.20250.64037.162,006,447.0010.68--11.59--89.26--52.72--5.34--0.0014--31.58--864.81------
Shanghai Conant Optical Co Ltd2.05bn405.16m6.07bn2.76k14.843.8812.952.970.95940.95944.843.670.93532.325.94815,548.5018.5212.5725.2718.6938.3735.2719.8014.641.70--0.130418.5712.7015.5631.5633.0413.49--
New Horizon Health Ltd1.46bn118.83m6.47bn1.04k59.472.0241.834.420.23780.23783.207.010.45362.162.081,666,325.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
LifeTech Scientific Corp1.38bn267.08m6.85bn1.41k24.611.8641.934.980.06010.06010.31110.7940.28770.6179.19951,249.001.817.092.168.5178.5879.666.3022.692.02--0.16350.0015.4817.88-19.0916.8026.11--
Kangji Medical Holdings Ltd1.05bn574.06m7.09bn964.0011.952.8012.466.730.49030.49030.89992.090.2291.835.071,050,468.0011.6414.4016.9016.1879.7881.7550.8457.241.74--0.0031111.8117.7621.235.2828.0041.50--
Data as of Nov 22 2024. Currency figures normalised to MicroPort NeuroScientic Corp's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

1.61%Per cent of shares held by top holders
HolderShares% Held
Bosera Asset Management Co., Ltd.as of 30 Jun 20242.79m0.48%
China Universal Asset Management Co., Ltd.as of 30 Jun 20242.75m0.47%
China Asset Management Co., Ltd.as of 30 Jun 20241.24m0.21%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2024627.00k0.11%
Fidelity Management & Research (Hong Kong) Ltd.as of 30 Sep 2024545.00k0.09%
Dimensional Fund Advisors LPas of 31 Jul 2024395.00k0.07%
Fidelity Management & Research Co. LLCas of 30 Sep 2024367.84k0.06%
China Asset Management (Hong Kong) Ltd.as of 30 Sep 2024273.29k0.05%
Mellon Investments Corp.as of 07 Nov 2024254.00k0.04%
BlackRock Advisors (UK) Ltd.as of 08 Nov 2024184.00k0.03%
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.